Hear experts address the gaps and limitations of CGP by using innovative simplified genomic profiling solutions that work for challenging samples not analyzable by CGP. Aspyre is a breakthrough technology that allows detection of DNA- and RNA-based biomarkers for all guideline-recommended genes associated with first-line NSCLC in a rapid turnaround time with exceptional sensitivity. In this webinar, you will learn how to:

Examine advantages of guideline-recommended genes associated with first-line NSCLC simplified genomic profiling (SGP) over CGP in NSCLC
Demonstrate the impact of a rapid 2-day TAT on NSCLC patient care
Maximize biomarker detection in challenging sample types
Evaluate the impact of benefits to patients and community with Aspyre technology

Watch the webinar on demand below.